253 related articles for article (PubMed ID: 28333845)
1. Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma.
van der Steen SCHA; Bulten J; Van de Vijver KK; van Kuppevelt TH; Massuger LFAG
Int J Gynecol Cancer; 2017 Jul; 27(6):1072-1081. PubMed ID: 28333845
[TBL] [Abstract][Full Text] [Related]
2. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
3. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract][Full Text] [Related]
4. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?
Gao FF; Bhargava R; Yang H; Li Z; Zhao C
Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279
[TBL] [Abstract][Full Text] [Related]
6. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
7. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
[TBL] [Abstract][Full Text] [Related]
8. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
9. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
Seidman JD
Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178
[TBL] [Abstract][Full Text] [Related]
10. Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.
Li HX; Lu ZH; Shen K; Cheng WJ; Malpica A; Zhang J; Wei JJ; Zhang ZH; Liu J
Int J Clin Exp Pathol; 2014; 7(3):848-57. PubMed ID: 24696706
[TBL] [Abstract][Full Text] [Related]
11. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP
Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267
[TBL] [Abstract][Full Text] [Related]
12. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.
Kuhn E; Meeker A; Wang TL; Sehdev AS; Kurman RJ; Shih IeM
Am J Surg Pathol; 2010 Jun; 34(6):829-36. PubMed ID: 20431479
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer.
Asaka S; Davis C; Lin SF; Wang TL; Heaphy CM; Shih IM
Am J Surg Pathol; 2019 Aug; 43(8):1083-1091. PubMed ID: 31107721
[TBL] [Abstract][Full Text] [Related]
14. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
Morrison JC; Blanco LZ; Vang R; Ronnett BM
Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma.
Sugimoto S; Uchiyama T; Kawahara N; Ohbayashi C; Kobayashi H
Int J Gynecol Pathol; 2021 Sep; 40(5):419-426. PubMed ID: 34397764
[TBL] [Abstract][Full Text] [Related]
16. Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.
Horn LC; Kafkova S; Leonhardt K; Kellner C; Einenkel J
Int J Gynecol Pathol; 2013 Jul; 32(4):339-44. PubMed ID: 23722505
[TBL] [Abstract][Full Text] [Related]
17. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
[TBL] [Abstract][Full Text] [Related]
19. IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis.
Wang Y; Li L; Wang Y; Yuan Z; Zhang W; Hatch KD; Zheng W
J Exp Clin Cancer Res; 2014 Jul; 33(1):60. PubMed ID: 25038792
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a Monoclonal Origin for Bilateral Serous Tubal Intraepithelial Neoplasia.
Meserve EE; Strickland KC; Miron A; Soong TR; Campbell F; Howitt BE; Crum CP
Int J Gynecol Pathol; 2019 Sep; 38(5):443-448. PubMed ID: 29901519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
